MedPath

The National Program for the Improvement of Management of Fetal Congenital Heart Disease in China

Not yet recruiting
Conditions
Congenital Heart Disease in Pregnancy
Fetal Echocardiography
Prenatal Diagnosis
Interventions
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
Registration Number
NCT05940363
Lead Sponsor
Beijing Anzhen Hospital
Brief Summary

To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling of congenital heart disease in medical institutions in China, in order to understand the current status and existing problems of prenatal prevention and treatment capacity of congenital heart disease in China, and to obtain corresponding baseline data, so as to provide scientific basis for further improving prenatal screening and diagnosis policies in China.

Detailed Description

With the rapid development of medical imaging technology, the role of ultrasound screening and diagnosis in the prevention and treatment of birth defects is increasingly prominent. Early screening, classified diagnosis, and standardized consultation are the basis for effective prevention and treatment of congenital heart disease. Due to the uneven development of medical resources and medical service levels in the eastern, central, and western regions of China, as well as between urban and rural areas, the ability of prenatal ultrasound screening, diagnosis, and clinical consultation varies greatly, and there is a lack of relevant clinical research data, which makes it difficult to adopt effective intervention measures. This study aims to investigate and analyze the prenatal screening, diagnosis, and consultation abilities of medical personnel in different regions, evaluate the current status and problems of congenital heart disease abilities in various regions, explore a multidisciplinary transfer consultation integrated service mechanism, strengthen comprehensive prevention and control abilities, ensure maternal and infant health.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
9000
Inclusion Criteria
  • All pregnant women and fetuses who underwent prenatal ultrasound examination in the above hospitals were enrolled
Exclusion Criteria
  • Pregnant women not willing to cooperate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Liaoning Provincial Maternal and Child Health HospitalImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesLiaoning Provincial Maternal and Child Health Hospital
Shenyang Maternal and Infant HospitalImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesShenyang Maternal and Infant Hospital
Guangdong Women and Children's HospitalImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesGuangdong Women and Children's Hospital
Guangdong Provincial People's HospitalImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesGuangdong Provincial People's Hospital
Peking University First Hospital, Ningxia Women and Children's HospitalImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesPeking University First Hospital, Ningxia Women and Children's Hospital
Shandong Maternal and Child Health HospitalImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesShandong Maternal and Child Health Hospital
Anhui Provincial Maternal and Child Health HospitalImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesAnhui Provincial Maternal and Child Health Hospital
Guangzhou Women and Children's Medical CenterImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesGuangzhou Women and Children's Medical Center
Fujian Provincial Maternal and Child Health HospitalImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesFujian Provincial Maternal and Child Health Hospital
Sichuan Maternal and Child Health HospitalImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesSichuan Maternal and Child Health Hospital
Maternal and Child Health Hospital of Hubei ProvinceImprovement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New TechnologiesMaternal and Child Health Hospital of Hubei Province
Primary Outcome Measures
NameTimeMethod
The integrity rate of the multi-view acquisitionFrom June 2023 to Oct 2023

The integrity rate of the multi-view acquisition

Negative coincidence rate congenital heart disease screeningFrom June 2023 to Oct 2023

Negative coincidence rate congenital heart disease screening

Positive coincidence rate of congenital heart disease screeningFrom June 2023 to Oct 2023

Positive coincidence rate of congenital heart disease screening

The coincidence rate of multidisciplinary consultationFrom June 2023 to Oct 2023

The coincidence rate of multidisciplinary consultation

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath